All News #Library
Biotech
Verastem, GenFleet Report GFH375 Ph1/2 KRAS G12D Pancreatic Data
19 Oct 2025 //
BUSINESSWIRE
Verastem Oncology Announces U.S. IND Clearance for VS-7375, Oral
23 Apr 2025 //
BUSINESSWIRE
Dupert Offers Hope As China`s First KRAS G12C Inhibitor For NSCLC
09 Sep 2024 //
EXPRESSPHARMA
GenFleet Announces First KRAS G12C Inhibitor Approval In China For NSCLC
23 Aug 2024 //
PR NEWSWIRE

Market Place
Sourcing Support